PEPTIDESTAT
Research onlyHealing & recoverySubcutaneousEvidence 2/5

BPC-157

Also known as: Body Protection Compound-157

Derived from human gastric juice. Animal models suggest effects on angiogenesis, tendon healing and GI repair; human clinical data is very limited.

Read guideBuy / compare source
BPC-157 product image
Drug class
Synthetic gastric peptide
Primary targets
Multiple pathways (preclinical)
Dose reference
No human dosing established
Half-life
Not well characterized in humans
Developer / origin
Sikiric et al. (academic origin)
Reference year
1991
Evidence score
2/5 - Mostly preclinical evidence
Evidence 2/5

Mostly preclinical evidence

BPC-157 has animal and mechanistic injury-model evidence, but human clinical efficacy and dosing are not established.

Mostly animal, ex vivo, cell, or indirect evidence.

Evidence basis

  • Animal injury models
  • Narrative/review literature
  • FDA safety-risk concerns for compounding

How to read this entry

Dose references and half-life values are pulled from trial protocols, labels, reviews, or published summaries where available. They are context for research and comparison, not a personal dosing recommendation.

Status matters: approved drugs have regulated indications; investigational compounds are still being studied; research-only peptides do not have established human dosing, safety, or efficacy for consumer use.

BPC-157 guides

Read the matching guide or adjacent research pages for more context.

BPC-157: What the Research Shows About the 'Healing Peptide'BPC-157 is widely marketed for recovery and tissue repair. Here's what the research actually shows — and the large gaps in human evidence.BPC-157 vs TB-500: Which Recovery Peptide Has Better Evidence?BPC-157 and TB-500 are both marketed for recovery, but their evidence is mostly preclinical. Here's the clean comparison.

Compare with related peptides

Stay inside the same research category and compare mechanism, status and evidence quality.

TB-500

Thymosin Beta-4 fragment

2/5
Healing & recoveryResearch only

Synthetic fragment of thymosin β4 studied in animal models for cell migration, angiogenesis and tissue repair. No approved human indication.

DetailsGuide

Category hub

Open the category page for the full comparison table and FAQ.

Healing Peptides

Compare healing peptides such as BPC-157 and TB-500 by evidence quality, mechanism, research status and practical limitations.

Research & educational purposes only

The information on PeptideStat is for educational and research purposes only and is not medical advice. Many peptides discussed are research compounds not approved for human use. Always consult a qualified healthcare professional before making any health decisions. Articles may contain affiliate links — we may earn a commission at no extra cost to you.